Frontiers in Cardiovascular Medicine (Sep 2022)
Effectiveness of SGLT2is vs. GLP-1RAs on cardiovascular and cerebrovascular outcomes in T2D patients according to CVD status
Abstract
No abstracts available.Keywords
Frontiers in Cardiovascular Medicine (Sep 2022)